 |
PDBsum entry 1f3h
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nat Struct Biol
7:602-608
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.
|
|
M.A.Verdecia,
H.Huang,
E.Dutil,
D.A.Kaiser,
T.Hunter,
J.P.Noel.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Survivin is a 16.5 kDa protein that is expressed during the G2/M phase of the
cell cycle and is hypothesized to inhibit a default apoptotic cascade initiated
in mitosis. This inhibitory function is coupled to survivin's localization to
the mitotic spindle. To begin to address the structural basis of survivin's
function, we report the X-ray crystal structure of a recombinant form of full
length survivin to 2.58 A resolution. Survivin consists of two defined domains
including an N-terminal Zn2+-binding BIR domain linked to a 65 A amphipathic
C-terminal alpha-helix. The crystal structure reveals an extensive dimerization
interface along a hydrophobic surface on the BIR domain of each survivin
monomer. A basic patch acting as a sulfate/phosphate-binding module, an acidic
cluster projecting off the BIR domain, and a solvent-accessible hydrophobic
surface residing on the C-terminal amphipathic helix, are suggestive of
functional protein-protein interaction surfaces.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Overall architecture of human survivin. a, Ribbon
representation of the survivin dimer. The Zn 2+ ion is shown as
a shaded sphere. Coordination bonds are shown as dotted orange
spheres. One monomer is blue; the other is rose. b, Orthogonal
view of the ribbon representation shown in (a). c, Perspective
and close up view of the Zn2+ binding site on one survivin
monomer. The depicted orientation corresponds to that pictured
in (a).
|
 |
Figure 3.
Figure 3. Surface features of human survivin. a, GRASP36
representation of the survivin solvent accessible surface
colored to approximately reflect the underlying electrostatic
potential, where blue is positive, red is negative and white is
neutral. Orientation is the same as in Fig. 2a. b, Orthogonal
view of that shown in (a). c, Perspective and close up view of
the sulfate binding site. The depicted orientation corresponds
to that pictured in Fig. 2b. d, Expanded view of one survivin
monomer illustrating the location of the 6
hydrophobic cluster.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Biol
(2000,
7,
602-608)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Venkatesan,
S.D.Prabhu,
K.Venkatachalam,
S.Mummidi,
A.J.Valente,
R.A.Clark,
P.Delafontaine,
and
B.Chandrasekar
(2010).
WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
|
| |
Cell Signal,
22,
809-820.
|
 |
|
|
|
|
 |
D.C.Altieri
(2010).
Survivin and IAP proteins in cell-death mechanisms.
|
| |
Biochem J,
430,
199-205.
|
 |
|
|
|
|
 |
R.Colnaghi,
and
S.P.Wheatley
(2010).
Liaisons between survivin and Plk1 during cell division and cell death.
|
| |
J Biol Chem,
285,
22592-22604.
|
 |
|
|
|
|
 |
Y.Shan,
C.Wang,
L.Yang,
L.J.Chen,
H.X.Deng,
H.S.Yang,
Z.Li,
Z.Li,
L.Pan,
F.Leng,
and
Y.Wei
(2010).
Inhibition of human lung adenocarcinoma growth using survivint34a by low-dose systematic administration.
|
| |
J Biosci,
35,
209-216.
|
 |
|
|
|
|
 |
L.Zhou,
J.Li,
R.George,
S.Ruchaud,
H.G.Zhou,
J.E.Ladbury,
W.C.Earnshaw,
and
X.Yuan
(2009).
Effects of full-length borealin on the composition and protein-protein interaction activity of a binary chromosomal passenger complex.
|
| |
Biochemistry,
48,
1156-1161.
|
 |
|
|
|
|
 |
D.C.Altieri
(2008).
Survivin, cancer networks and pathway-directed drug discovery.
|
| |
Nat Rev Cancer,
8,
61-70.
|
 |
|
|
|
|
 |
D.C.Altieri
(2008).
New wirings in the survivin networks.
|
| |
Oncogene,
27,
6276-6284.
|
 |
|
|
|
|
 |
H.Sun,
J.A.Stuckey,
Z.Nikolovska-Coleska,
D.Qin,
J.L.Meagher,
S.Qiu,
J.Lu,
C.Y.Yang,
N.G.Saito,
and
S.Wang
(2008).
Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP).
|
| |
J Med Chem,
51,
7169-7180.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.M.Srinivasula,
and
J.D.Ashwell
(2008).
IAPs: what's in a name?
|
| |
Mol Cell,
30,
123-135.
|
 |
|
|
|
|
 |
T.Minematsu,
L.Felder,
T.Oppeneer,
M.Sakazume,
K.Oikawa,
T.Hashimoto,
T.Usui,
and
H.Kamimura
(2008).
Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of YM155, a novel small-molecule survivin suppressant, in dog plasma.
|
| |
Biomed Chromatogr,
22,
763-769.
|
 |
|
|
|
|
 |
Z.Yue,
A.Carvalho,
Z.Xu,
X.Yuan,
S.Cardinale,
S.Ribeiro,
F.Lai,
H.Ogawa,
E.Gudmundsdottir,
R.Gassmann,
C.G.Morrison,
S.Ruchaud,
and
W.C.Earnshaw
(2008).
Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line.
|
| |
J Cell Biol,
183,
279-296.
|
 |
|
|
|
|
 |
E.Bourhis,
S.G.Hymowitz,
and
A.G.Cochran
(2007).
The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin.
|
| |
J Biol Chem,
282,
35018-35023.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Kaur,
A.C.Stiff,
D.A.Date,
and
W.R.Taylor
(2007).
Analysis of mitotic phosphorylation of borealin.
|
| |
BMC Cell Biol,
8,
5.
|
 |
|
|
|
|
 |
P.Lechler,
X.Wu,
W.Bernhardt,
V.Campean,
S.Gastiger,
T.Hackenbeck,
B.Klanke,
A.Weidemann,
C.Warnecke,
K.Amann,
D.Engehausen,
C.Willam,
K.U.Eckardt,
F.Rödel,
and
M.S.Wiesener
(2007).
The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.
|
| |
Am J Pathol,
171,
1483-1498.
|
 |
|
|
|
|
 |
S.Carelli,
E.Lesma,
S.Paratore,
V.Grande,
G.Zadra,
S.Bosari,
A.M.Di Giulio,
and
A.Gorio
(2007).
Survivin expression in tuberous sclerosis complex cells.
|
| |
Mol Med,
13,
166-177.
|
 |
|
|
|
|
 |
S.K.Singh,
D.Moretta,
F.Almaguel,
N.R.Wall,
M.De León,
and
D.De León
(2007).
Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells.
|
| |
Growth Factors,
25,
363-372.
|
 |
|
|
|
|
 |
S.Y.Park,
E.Y.Kim,
K.Jeon,
X.S.Cui,
W.D.Lee,
N.H.Kim,
S.P.Park,
and
J.H.Lim
(2007).
Survivin acts as anti-apoptotic factor during the development of bovine pre-implantation embryos.
|
| |
Mol Reprod Dev,
74,
582-590.
|
 |
|
|
|
|
 |
T.Dohi,
F.Xia,
and
D.C.Altieri
(2007).
Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection.
|
| |
Mol Cell,
27,
17-28.
|
 |
|
|
|
|
 |
D.E.Zhu,
N.Höti,
Z.Song,
L.Jin,
Z.Wu,
Q.Wu,
and
M.Wu
(2006).
Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
|
| |
Cancer Gene Ther,
13,
762-770.
|
 |
|
|
|
|
 |
E.A.Noton,
R.Colnaghi,
S.Tate,
C.Starck,
A.Carvalho,
P.Ko Ferrigno,
and
S.P.Wheatley
(2006).
Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis.
|
| |
J Biol Chem,
281,
1286-1295.
|
 |
|
|
|
|
 |
G.Vader,
R.H.Medema,
and
S.M.Lens
(2006).
The chromosomal passenger complex: guiding Aurora-B through mitosis.
|
| |
J Cell Biol,
173,
833-837.
|
 |
|
|
|
|
 |
H.G.Nguyen,
and
K.Ravid
(2006).
Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins.
|
| |
J Cell Physiol,
208,
12-22.
|
 |
|
|
|
|
 |
M.A.Pratt,
M.Y.Niu,
and
L.I.Renart
(2006).
Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
|
| |
Apoptosis,
11,
589-605.
|
 |
|
|
|
|
 |
S.M.Lens,
J.A.Rodriguez,
G.Vader,
S.W.Span,
G.Giaccone,
and
R.H.Medema
(2006).
Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres.
|
| |
Mol Biol Cell,
17,
1897-1909.
|
 |
|
|
|
|
 |
U.R.Klein,
E.A.Nigg,
and
U.Gruneberg
(2006).
Centromere targeting of the chromosomal passenger complex requires a ternary subcomplex of Borealin, Survivin, and the N-terminal domain of INCENP.
|
| |
Mol Biol Cell,
17,
2547-2558.
|
 |
|
|
|
|
 |
F.Li,
X.Ling,
H.Huang,
L.Brattain,
P.Apontes,
J.Wu,
L.Binderup,
and
M.G.Brattain
(2005).
Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines.
|
| |
Oncogene,
24,
1385-1395.
|
 |
|
|
|
|
 |
G.Ferrandina,
F.Legge,
E.Martinelli,
F.O.Ranelletti,
G.F.Zannoni,
L.Lauriola,
M.Gessi,
V.Gallotta,
and
G.Scambia
(2005).
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.
|
| |
Br J Cancer,
92,
271-277.
|
 |
|
|
|
|
 |
H.K.Huang,
J.M.Bailis,
J.D.Leverson,
E.B.Gómez,
S.L.Forsburg,
and
T.Hunter
(2005).
Suppressors of Bir1p (Survivin) identify roles for the chromosomal passenger protein Pic1p (INCENP) and the replication initiation factor Psf2p in chromosome segregation.
|
| |
Mol Cell Biol,
25,
9000-9015.
|
 |
|
|
|
|
 |
M.Minczuk,
S.Mroczek,
S.D.Pawlak,
and
P.P.Stepien
(2005).
Human ATP-dependent RNA/DNA helicase hSuv3p interacts with the cofactor of survivin HBXIP.
|
| |
FEBS J,
272,
5008-5019.
|
 |
|
|
|
|
 |
Q.P.Vong,
K.Cao,
H.Y.Li,
P.A.Iglesias,
and
Y.Zheng
(2005).
Chromosome alignment and segregation regulated by ubiquitination of survivin.
|
| |
Science,
310,
1499-1504.
|
 |
|
|
|
|
 |
A.Chandele,
V.Prasad,
J.C.Jagtap,
R.Shukla,
and
P.R.Shastry
(2004).
Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis.
|
| |
Neoplasia,
6,
29-40.
|
 |
|
|
|
|
 |
A.Martinez,
B.Bellosillo,
F.Bosch,
A.Ferrer,
S.Marcé,
N.Villamor,
G.Ott,
E.Montserrat,
E.Campo,
and
D.Colomer
(2004).
Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival.
|
| |
Am J Pathol,
164,
501-510.
|
 |
|
|
|
|
 |
D.C.Altieri
(2004).
Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm.
|
| |
J Cell Biochem,
92,
656-663.
|
 |
|
|
|
|
 |
E.Beltrami,
J.Plescia,
J.C.Wilkinson,
C.S.Duckett,
and
D.C.Altieri
(2004).
Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis.
|
| |
J Biol Chem,
279,
2077-2084.
|
 |
|
|
|
|
 |
P.Vagnarelli,
and
W.C.Earnshaw
(2004).
Chromosomal passengers: the four-dimensional regulation of mitotic events.
|
| |
Chromosoma,
113,
211-222.
|
 |
|
|
|
|
 |
T.Liu,
B.Brouha,
and
D.Grossman
(2004).
Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells.
|
| |
Oncogene,
23,
39-48.
|
 |
|
|
|
|
 |
X.Ling,
R.J.Bernacki,
M.G.Brattain,
and
F.Li
(2004).
Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest.
|
| |
J Biol Chem,
279,
15196-15203.
|
 |
|
|
|
|
 |
Z.Song,
S.Liu,
H.He,
N.Hoti,
Y.Wang,
S.Feng,
and
M.Wu
(2004).
A single amino acid change (Asp 53 --> Ala53) converts Survivin from anti-apoptotic to pro-apoptotic.
|
| |
Mol Biol Cell,
15,
1287-1296.
|
 |
|
|
|
|
 |
Z.Xing,
E.M.Conway,
C.Kang,
and
A.Winoto
(2004).
Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.
|
| |
J Exp Med,
199,
69-80.
|
 |
|
|
|
|
 |
E.M.Conway,
F.Zwerts,
V.Van Eygen,
A.DeVriese,
N.Nagai,
W.Luo,
and
D.Collen
(2003).
Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation.
|
| |
Am J Pathol,
163,
935-946.
|
 |
|
|
|
|
 |
F.Li
(2003).
Survivin study: what is the next wave?
|
| |
J Cell Physiol,
197,
8.
|
 |
|
|
|
|
 |
H.Marusawa,
S.Matsuzawa,
K.Welsh,
H.Zou,
R.Armstrong,
I.Tamm,
and
J.C.Reed
(2003).
HBXIP functions as a cofactor of survivin in apoptosis suppression.
|
| |
EMBO J,
22,
2729-2740.
|
 |
|
|
|
|
 |
J.Chen,
S.Jin,
S.K.Tahir,
H.Zhang,
X.Liu,
A.V.Sarthy,
T.P.McGonigal,
Z.Liu,
S.H.Rosenberg,
and
S.C.Ng
(2003).
Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells.
|
| |
J Biol Chem,
278,
486-490.
|
 |
|
|
|
|
 |
P.Fortugno,
E.Beltrami,
J.Plescia,
J.Fontana,
D.Pradhan,
P.C.Marchisio,
W.C.Sessa,
and
D.C.Altieri
(2003).
Regulation of survivin function by Hsp90.
|
| |
Proc Natl Acad Sci U S A,
100,
13791-13796.
|
 |
|
|
|
|
 |
Z.Song,
X.Yao,
and
M.Wu
(2003).
Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis.
|
| |
J Biol Chem,
278,
23130-23140.
|
 |
|
|
|
|
 |
C.Mahotka,
T.Krieg,
A.Krieg,
M.Wenzel,
C.V.Suschek,
M.Heydthausen,
H.E.Gabbert,
and
C.D.Gerharz
(2002).
Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.
|
| |
Int J Cancer,
100,
30-36.
|
 |
|
|
|
|
 |
H.W.Wang,
T.V.Sharp,
A.Koumi,
G.Koentges,
and
C.Boshoff
(2002).
Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.
|
| |
EMBO J,
21,
2602-2615.
|
 |
|
|
|
|
 |
J.D.Leverson,
H.K.Huang,
S.L.Forsburg,
and
T.Hunter
(2002).
The Schizosaccharomyces pombe aurora-related kinase Ark1 interacts with the inner centromere protein Pic1 and mediates chromosome segregation and cytokinesis.
|
| |
Mol Biol Cell,
13,
1132-1143.
|
 |
|
|
|
|
 |
J.Tran,
Z.Master,
J.L.Yu,
J.Rak,
D.J.Dumont,
and
R.S.Kerbel
(2002).
A role for survivin in chemoresistance of endothelial cells mediated by VEGF.
|
| |
Proc Natl Acad Sci U S A,
99,
4349-4354.
|
 |
|
|
|
|
 |
K.Nakayama,
and
S.Kamihira
(2002).
Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology.
|
| |
Leuk Lymphoma,
43,
2249-2255.
|
 |
|
|
|
|
 |
L.E.Luque,
K.P.Grape,
and
M.Junker
(2002).
A highly conserved arginine is critical for the functional folding of inhibitor of apoptosis (IAP) BIR domains.
|
| |
Biochemistry,
41,
13663-13671.
|
 |
|
|
|
|
 |
M.A.Bolton,
W.Lan,
S.E.Powers,
M.L.McCleland,
J.Kuang,
and
P.T.Stukenberg
(2002).
Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation.
|
| |
Mol Biol Cell,
13,
3064-3077.
|
 |
|
|
|
|
 |
D.Grossman,
P.J.Kim,
O.P.Blanc-Brude,
D.E.Brash,
S.Tognin,
P.C.Marchisio,
and
D.C.Altieri
(2001).
Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.
|
| |
J Clin Invest,
108,
991-999.
|
 |
|
|
|
|
 |
J.R.Kanwar,
W.P.Shen,
R.K.Kanwar,
R.W.Berg,
and
G.W.Krissansen
(2001).
Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy.
|
| |
J Natl Cancer Inst,
93,
1541-1552.
|
 |
|
|
|
|
 |
M.Mesri,
N.R.Wall,
J.Li,
R.W.Kim,
and
D.C.Altieri
(2001).
Cancer gene therapy using a survivin mutant adenovirus.
|
| |
J Clin Invest,
108,
981-990.
|
 |
|
|
|
|
 |
D.A.Skoufias,
C.Mollinari,
F.B.Lacroix,
and
R.L.Margolis
(2000).
Human survivin is a kinetochore-associated passenger protein.
|
| |
J Cell Biol,
151,
1575-1582.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |